首页> 外文会议>International Symposium on Hormonal Carcinogenesis >Presence of CCK-B Receptor mRNA in Human Functionless Pituitary Tumors
【24h】

Presence of CCK-B Receptor mRNA in Human Functionless Pituitary Tumors

机译:在人无能为力垂体肿瘤中存在CCK-B受体mRNA

获取原文

摘要

Cholecystokinin (CCK) is a peptide found widely distributed throughout the gut and nervous systems. There is growing evidence that it affects growth and differentiation of several types of cell, including anterior pituitary cells, via two receptor subtypes, A and B. An autocrine/paracrine role for CCK in GH3 rat pituitary tumor cells has been reported. Herein, we demonstrate that functionless human pituitary tumors also possess CCK-B receptors. Total RNA was extracted from 30 human functionless pituitary tumors, reverse transcribed into cDNA, and subjected to PCR using primers specific for CCK-A and CCK-B receptors. The primers were targeted against different exons of the receptor genes, allowing identification of cDNA amplification. PCR bands of the predicted length were observed in all tumors using CCK-B receptor primers. Restriction digestion and direct sequence analysis of the products provided further evidence that they represented CCK-B receptor mRNA. CCK-A receptor mRNA was not detected by this RT-PCR analysis. In culture, CCK and CCK octapeptide sulphate powerfully stimulated phosphatidylinositol hydrolysis, providing evidence for functional activity of the CCK-B receptors. Similar analyses on pituitary-derived fibroblasts yielded negative results, indicating that the CCK-B receptor mRNA was expressed by tumors cells. These results suggest a role for CCK in the development of human functionless pituitary tumors.
机译:Cholecystokinin(CCK)是发现在整个肠道和神经系统中广泛分布的肽。越来越多的证据表明,它影响了几种类型的细胞的生长和分化,包括前脑垂体细胞,通过两种受体亚型,A和B.已经报道了GH3大鼠垂体肿瘤细胞中CCK的自分泌/旁静脉作用。在此,我们证明无效的人脑垂体肿瘤也具有CCK-B受体。从30个人无效的垂体肿瘤中提取总RNA,逆转录成cDNA,并使用针对CCK-A和CCK-B受体的引物进行PCR。将引物针对受体基因的不同外显子靶向,允许鉴定cDNA扩增。使用CCK-B受体引物在所有肿瘤中观察到预测长度的PCR带。对产品的限制消化和直接序列分析提供了它们代表CCK-B受体mRNA的进一步证据。该RT-PCR分析未检测到CCK-A受体mRNA。在培养物中,CCK和CCK八肽硫酸盐有力刺激磷脂酰肌醇水解,为CCK-B受体的功能活性提供证据。在垂体衍生的成纤维细胞上类似的分析产生了阴性结果,表明CCK-B受体mRNA由肿瘤细胞表达。这些结果表明CCK在人类无能为力垂体肿瘤的发展中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号